- Intermediate
- Varenicline tartrate 230615-70-0
- Aprepitant 287930-73-8
- Aprepitant 127852-28-2
- Aprepitant 287930-75-0
- Aprepitant 200000-59-5
- Aprepitant 155742-64-6
- Aprepitant 252742-72-6
- Fosaprepitant Dimeglumine 990-91-0
- Fosaprepitant Dimeglumine 265121-01-5
- Vildagliptin 207557-35-5
- Vildagliptin 702-82-9
- Efinaconazole 144230-50-2
- Efinaconazole 133775-25-4
- Efinaconazole 127000-90-2
- Gadoterate Meglumine
- Mirabegron
- Luliconazole 98873-55-3
- Luliconazole 126534-31-4
- Atazanavir sulfate
- Bortezomib 179324-87-9
- Bortezomib 114457-94-2
- Bortezomib 205393-22-2
- Brinzolamide
- Rivaroxaban Intermediate 446292-08-6
- Rivaroxaban Intermediate 446292-07-5
- Cinacalcet Hydrochloride 1005450-55-4
- Cinacalcet Hydrochloride 585-50-2
- Eletriptan Intermediate
- Indacaterol intermediate 312753-53-0
- Indacaterol intermediate 173140-90-4
- Sitagliptin Intermediate
- Fosanavir Calcium Intermediate
News Center
Indate maleate intermediate 173140-90-4
【Catalog number】AP4501
【CAS #】 173140-90-4
【Molecular formula】 C18H15NO3
【Molecular Weight】293.31
|
Alias |
Indate maleate intermediate |
|
Catalog Number |
AP4501 |
|
CAS # |
173140-90-4 |
|
Molecular Formula |
C18H15NO3 |
|
Molecular Weight |
293.31 |
|
Structural Formula |
|
|
Product Introduction CAS 173140-90-4 |
5- (2R) -2-oxiranyl-8-benzyloxy-2 (1H) -quinolinone, English name is 5- (2R) -2-Oxiranyl-8-benzyloxy-2 (1H) -quinolinone, American Chemical Abstracts Registration Number is cas 173140-90-4. 5- (2R) -2-oxiranyl-8-benzyloxy-2 (1H) -quinolinone (cas 173140-90-4) is an intermediate of indate maleate. Indate maleate is a bronchodilator, belongs to the class of long-acting inhaled β2 receptor agonists (LABA), and is suitable for maintenance treatment of adult patients with chronic obstructive pulmonary disease. Indacaterol has a 5 minute onset and lasts 24 hours. This product is produced by Novartis Pharmaceuticals, Switzerland, and has been marketed in more than 70 countries and regions around the world since 2009; it was approved for listing in China by the State Drug Administration in June 2012 under the trade name Onbrez®. |
VIWIT 沪ICP备12014533号-2
